HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 342 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $34,486 | +1.0% | 903 | +50.5% | 0.00% | 0.0% |
| Q4 2022 | $34,140 | +3314.0% | 600 | +3650.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 16 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | -88.9% | 16 | -95.3% | 0.00% | – |
| Q3 2020 | $9,000 | -35.7% | 339 | -58.3% | 0.00% | -100.0% |
| Q3 2019 | $14,000 | 0.0% | 812 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $14,000 | +7.7% | 812 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $13,000 | +8.3% | 812 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $12,000 | -20.0% | 812 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $15,000 | +7.1% | 812 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $14,000 | -72.5% | 812 | -68.9% | 0.00% | -75.0% |
| Q1 2018 | $51,000 | -30.1% | 2,612 | -27.7% | 0.00% | -33.3% |
| Q4 2017 | $73,000 | -27.7% | 3,612 | -37.7% | 0.01% | -50.0% |
| Q3 2017 | $101,000 | – | 5,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |